142 related articles for article (PubMed ID: 3956136)
1. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
Ho JL; Klempner MS
Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Baltch AL; Ritz WJ; Bopp LH; Michelsen PB; Smith RP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1559-62. PubMed ID: 17283190
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
[TBL] [Abstract][Full Text] [Related]
4. Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):920-2. PubMed ID: 7181497
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus.
Johnston BL; Kwok RY; Mulligan ME
Diagn Microbiol Infect Dis; 1987 Nov; 8(3):137-47. PubMed ID: 3440369
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.
Tuazon CU; Lin MY; Sheagren JN
Antimicrob Agents Chemother; 1978 May; 13(5):759-61. PubMed ID: 666300
[TBL] [Abstract][Full Text] [Related]
7. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.
Dumitrescu O; Badiou C; Bes M; Reverdy ME; Vandenesch F; Etienne J; Lina G
Clin Microbiol Infect; 2008 Apr; 14(4):384-8. PubMed ID: 18261123
[TBL] [Abstract][Full Text] [Related]
8. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
Bayer AS; Morrison JO
Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.
Maduri Traczewski M; Goldmann DA; Murphy P
Antimicrob Agents Chemother; 1983 Apr; 23(4):571-6. PubMed ID: 6859835
[TBL] [Abstract][Full Text] [Related]
10. Antistaphylococcal activity of rifampin with other antibiotics.
Zinner SH; Lagast H; Klastersky J
J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
[TBL] [Abstract][Full Text] [Related]
11. Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphyloccus aureus.
Bakar NS; Zin NM; Basri DF
Pak J Pharm Sci; 2012 Jul; 25(3):633-8. PubMed ID: 22713953
[TBL] [Abstract][Full Text] [Related]
12. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
[TBL] [Abstract][Full Text] [Related]
13. In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Baltch AL; Bassey C; Fanciullo G; Smith RP
J Antimicrob Chemother; 1987 Jan; 19(1):45-8. PubMed ID: 3104277
[TBL] [Abstract][Full Text] [Related]
14. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Voss A; Machka K; Lenz W; Milatovic D
Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
[TBL] [Abstract][Full Text] [Related]
15. In vitro study of the combination of rifampin with oxacillin against Staphylococcus aureus.
Van der Auwera P; Klastersky J
Rev Infect Dis; 1983; 5 Suppl 3():S509-14. PubMed ID: 6635442
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci.
Domaracki BE; Evans AM; Venezia RA
Antimicrob Agents Chemother; 2000 May; 44(5):1394-6. PubMed ID: 10770789
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
Tuazon CU; Miller H
Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.
Baiocchi P; Galiè M; Santini C; Carfagna P; Cassone M; Tarasi D; Venditti M
J Chemother; 1998 Feb; 10(1):25-8. PubMed ID: 9531072
[TBL] [Abstract][Full Text] [Related]
19. The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus.
Iluz N; Maor Y; Keller N; Malik Z
Lasers Surg Med; 2018 Jul; 50(5):535-551. PubMed ID: 29333608
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
